中国医药
(600056)
| 流通市值：167.18亿 | | | 总市值：167.24亿 |
| 流通股本：14.95亿 | | | 总股本：14.96亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 3,029,030,650.11 | 3,644,447,878.79 | 3,038,127,012.26 | 4,260,346,745.99 |
| 衍生金融资产 | 457,856.73 | 156,316.05 | 951,400.89 | 123,590.78 |
| 应收票据及应收账款 | 15,900,716,932.52 | 16,468,126,280.77 | 15,764,690,230.36 | 13,499,084,447.93 |
| 其中：应收票据 | 380,722,983.8 | 498,263,396.7 | 323,500,220.72 | 345,411,341.84 |
| 应收账款 | 15,519,993,948.72 | 15,969,862,884.07 | 15,441,190,009.64 | 13,153,673,106.09 |
| 应收款项融资 | 519,955,921.47 | 368,484,227.52 | 382,497,725.8 | 474,183,386.76 |
| 预付款项 | 934,116,072.88 | 1,019,084,318.07 | 1,139,040,381.06 | 1,224,403,204.71 |
| 其他应收款合计 | 1,212,497,655.59 | 1,099,720,607.2 | 1,182,118,075.5 | 1,043,068,825.03 |
| 存货 | 6,910,980,506.83 | 7,216,543,101.67 | 7,621,414,310.77 | 6,083,411,981.21 |
| 合同资产 | 24,090,346.02 | 24,185,837.51 | 11,783,467.88 | 12,390,947.01 |
| 一年内到期的非流动资产 | 82,635,319.5 | 76,819,369.5 | 104,513,314.47 | 109,750,894.81 |
| 其他流动资产 | 455,323,943.59 | 441,622,141.93 | 504,849,270.2 | 227,744,251.49 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 29,069,805,205.24 | 30,359,190,079.01 | 29,749,985,189.19 | 26,934,508,275.72 |
| 非流动资产: | | | | |
| 长期应收款 | 61,211,295.14 | 88,207,612.61 | 80,089,087.5 | 132,503,036.2 |
| 长期股权投资 | 2,636,327,613.06 | 2,628,362,613.06 | 2,591,487,576.51 | 2,570,613,876.51 |
| 其他权益工具投资 | 55,841,983.69 | 55,841,983.69 | 55,841,983.69 | 55,841,983.69 |
| 投资性房地产 | 90,888,963.83 | 89,718,613.95 | 90,714,285.86 | 96,603,914.25 |
| 固定资产 | 2,248,468,627.45 | 2,285,325,097.49 | 2,320,444,959.79 | 2,340,409,994.35 |
| 在建工程 | 271,556,758.66 | 245,354,536.45 | 223,251,362.93 | 201,196,305.16 |
| 使用权资产 | 342,327,255.44 | 346,173,485.42 | 226,146,452.09 | 238,785,793.69 |
| 无形资产 | 549,712,934.72 | 487,839,683.82 | 474,165,405.43 | 485,672,741.85 |
| 开发支出 | 458,272,270.93 | 458,666,022.74 | 433,428,325.83 | 408,196,424.84 |
| 商誉 | 1,123,822,084.62 | 1,123,822,084.62 | 1,123,822,084.62 | 1,123,822,084.62 |
| 长期待摊费用 | 132,633,818.4 | 116,361,595.69 | 123,439,817.41 | 117,988,357.25 |
| 递延所得税资产 | 660,522,456.75 | 667,775,781.36 | 674,501,656.22 | 660,433,806.85 |
| 其他非流动资产 | 484,813,707.97 | 504,689,204.86 | 442,726,936.31 | 532,035,977.1 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 9,116,399,770.66 | 9,098,138,315.76 | 8,860,059,934.19 | 8,964,104,296.36 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 38,186,204,975.9 | 39,457,328,394.77 | 38,610,045,123.38 | 35,898,612,572.08 |
| 流动负债: | | | | |
| 短期借款 | 2,053,924,652.62 | 2,072,117,380.29 | 1,836,444,636.26 | 997,638,872.5 |
| 应付票据及应付账款 | 10,660,297,017.84 | 11,099,561,926.24 | 11,407,597,708.83 | 8,770,630,199.46 |
| 其中：应付票据 | 1,180,880,989.97 | 1,126,917,647.67 | 1,300,449,087.4 | 1,186,589,312.89 |
| 应付账款 | 9,479,416,027.87 | 9,972,644,278.57 | 10,107,148,621.43 | 7,584,040,886.57 |
| 预收款项 | 1,586,793.52 | 5,084,863.39 | 1,632,818.94 | 4,850,480.82 |
| 合同负债 | 1,565,076,247.59 | 1,786,484,130.64 | 1,504,880,995.34 | 2,045,319,291.68 |
| 应付职工薪酬 | 279,793,366.58 | 278,833,163.66 | 287,218,080.35 | 338,582,049.31 |
| 应交税费 | 139,136,138.31 | 162,214,892.74 | 186,271,962.16 | 225,147,008 |
| 其他应付款合计 | 3,928,128,648.48 | 3,944,417,708.81 | 3,724,612,962.53 | 3,320,252,502.55 |
| 应付股利 | 5,277,829.97 | 5,277,829.97 | 5,199,883.73 | 5,199,883.73 |
| 一年内到期的非流动负债 | 72,792,087.65 | 109,653,664.58 | 58,489,511.6 | 1,946,428,688.89 |
| 其他流动负债 | 337,652,043.49 | 375,731,508.4 | 237,490,977.99 | 363,895,896.94 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 19,038,386,996.08 | 19,834,099,238.75 | 19,244,639,654 | 18,012,744,990.15 |
| 非流动负债: | | | | |
| 长期借款 | 3,023,356,829.3 | 3,568,356,829.3 | 3,568,356,829.3 | 2,250,000,000 |
| 租赁负债 | 294,249,847.1 | 257,564,788.44 | 183,294,108.13 | 185,868,834.02 |
| 长期应付款 | 2,048,743,807.91 | 2,062,452,731.25 | 2,023,563,290.65 | 2,180,558,450.63 |
| 长期应付职工薪酬 | 7,774,229.68 | 7,774,229.68 | 7,803,250.77 | 7,774,229.68 |
| 递延收益 | 70,772,826.66 | 72,977,820.37 | 73,696,514.08 | 73,976,275.39 |
| 递延所得税负债 | 14,601,300.27 | 14,710,142.38 | 14,693,121.75 | 14,602,721.55 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 5,459,498,840.92 | 5,983,836,541.42 | 5,871,407,114.68 | 4,712,780,511.27 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 24,497,885,837 | 25,817,935,780.17 | 25,116,046,768.68 | 22,725,525,501.42 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,495,879,748 | 1,495,879,748 | 1,495,879,748 | 1,495,879,748 |
| 资本公积 | 2,052,839,804.88 | 2,052,839,804.88 | 2,052,839,804.88 | 2,052,839,804.88 |
| 其他综合收益 | 25,882,849.98 | 26,795,498.96 | 25,499,225.76 | 25,176,228.34 |
| 盈余公积 | 578,649,037.82 | 578,649,037.82 | 578,649,037.82 | 578,649,037.82 |
| 未分配利润 | 7,036,626,926.32 | 6,986,064,023.8 | 6,932,003,543.12 | 6,663,233,402.19 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 11,189,878,367 | 11,140,228,113.46 | 11,084,871,359.58 | 10,815,778,221.23 |
| 少数股东权益 | 2,498,440,771.9 | 2,499,164,501.14 | 2,409,126,995.12 | 2,357,308,849.43 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 13,688,319,138.9 | 13,639,392,614.6 | 13,493,998,354.7 | 13,173,087,070.66 |
| 负债和股东权益合计 | 38,186,204,975.9 | 39,457,328,394.77 | 38,610,045,123.38 | 35,898,612,572.08 |
| 公告日期 | 2023-10-28 | 2023-08-25 | 2023-04-29 | 2023-04-29 |
| 审计意见(境内) | | | | 标准无保留意见 |